Recombinant Rat NGAL Protein，His

NGAL (Neutrophil Gelatinase-Associated Lipocalin) is a small, secreted protein that plays a significant role in various physiological and pathological processes, particularly in the context of acute kidney injury (AKI) and inflammation. As a component of the lipocalin family, NGAL binds to small hydrophobic molecules and is involved in the transport of these molecules, which contributes to its diverse biological functions. Elevated levels of NGAL in urine and serum have been identified as promising early biomarkers for AKI, facilitating early diagnosis and intervention. Research into recombinant NGAL (rNGAL) focuses on its potential therapeutic applications, as well as its mechanistic role in kidney protection and repair. The production of rNGAL using recombinant DNA technology allows for the study of its structure, function, and interaction with other proteins, making it a valuable tool for investigating renal pathology. Moreover, the potential use of rNGAL as a biomarker or therapeutic agent has spurred interest in understanding its modulatory effects on inflammation and fibrosis within the kidneys. By delineating the role of NGAL in renal physiology and disease, researchers aim to develop targeted strategies for preventing or treating AKI and improving patient outcomes.